June 6, 2017August 24, 2022
University of Michigan Researchers Identify 16 New Genetic Markers That Shed Light on Psoriasis
News
University of Michigan researchers have shed more light on the genetic landscape behind the intricate mechanisms of psoriasis. The 16 ... Read more
June 1, 2017
OWCP and mediq Collaborate to Introduce Cannabinoid-based Psoriasis Cream in Germany
News
One World Cannabis Pharmaceutical Research (OWCP) and mediq Innovation Experts have partnered to introduce OWCP’s cannabinoid-based topical psoriasis cream in Germany. ... Read more
May 30, 2017May 30, 2017
FDA Approves BLA Filing for Sun Pharma’s Lead Candidate Therapy Tildrakizumab to Treat Plaque Psoriasis
News
The U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) for Sun Pharmaceutical’s lead investigational drug tildrakizumab ... Read more
May 25, 2017May 25, 2017
Janssen’s Phase 3 Trials for Guselkumab to Focus on Plaque Psoriasis, Psoriatic Arthritis
News
Janssen announced two new Phase 3 clinical trials for psoriasis for its investigational drug guselkumab. The company intends to explore ... Read more
May 23, 2017
Remicade Can Be Substituted for Less Expensive Biosimilar CT-P13, Clinical Trial Suggests
News
Patients taking Remicade (infliximab) can safely switch to treatment with biosimilar CT-P13, sold as Pfizer’s Inflectra and Celltrion Healthcare’s Remsima, according to ... Read more
May 16, 2017May 16, 2017
Cannabinoids Have Potential to Treat Skin Conditions Like Psoriasis, Review Shows
News
Compounds extracted from the cannabis plant (cannabinoids) have therapeutic proprieties that could be used to treat several skin conditions, including psoriasis, ... Read more
May 11, 2017
Phase 2b Trial of Psoriasis Therapy Prurisol Reaches 70% of Participant Target
News
An already started Phase 2b clinical trial of Prurisol as a treatment for moderate-to-severe chronic plaque psoriasis has recruited more than 70 ... Read more
May 9, 2017
Pfizer’s Xeljanz Reduced Nail Psoriasis in Phase 3 Trials of Plaque Disease
News
Pfizer’s rheumatoid arthritis drug Xeljanz (tofacitinib) was effective against nail psoriasis in patients with plaque disease, according to data from ... Read more
May 4, 2017May 4, 2017
FDA Accepts Pfizer’s Supplemental New Drug Application for Xeljanz to Treat Active Psoriatic Arthritis Patients
News
The U.S. Food and Drug Administration (FDA) will review Pfizer’s medication Xeljanz (tofacitinib citrate) 5 mg twice daily, to treat adults with ... Read more
May 2, 2017
Cimzia and Cosentyx Approved to Treat Active Psoriatic Arthritis in England and Wales
News
The U.K.’s National Institute for Health and Care Excellence (NICE) has approved the use of Cimzia (certolizumab pegol) and Cosentyx (secukinumab), ... Read more
April 27, 2017April 27, 2017
Valeant Prices Plaque Psoriasis Treatment, Siliq, at $3,500 a Month
News
Siliq (brodalumab) injection, recently approved to treat adults with severe plaque psoriasis, will be available in the U.S. at a ... Read more
April 20, 2017April 20, 2017
XTRAC Light Therapy Effectively Treats Psoriasis Lesions Without the Serious Side Effects of Rival Therapies, Says Strata
News
XTRAC targeted-light therapy safely treats skin lesions in psoriasis patients without the serious side effects linked to Humira and other conventional psoriasis drugs, ... Read more

August 2, 2016August 2, 2016

Generic Biologics for Psoriasis Similar in Safety and Efficacy to Brand Names, Study Finds

News

Researchers have found that generic forms of a biologic drug used to treat inflammatory diseases such as psoriasis and rheumatoid arthritis are as safe and effective as the brand-name equivalent. ... Read more

August 1, 2016August 1, 2016

Moderate-to-Severe Psoriasis May Be Treated Using Mix of Biologic and Light Therapies

News

A combination of biologic and phototherapy treatments appear to be a viable clinical strategy for people with moderate-to-severe psoriasis who do not respond to either as monotherapy, according to a recent systematic review. ... Read more

July 29, 2016July 29, 2016

Psoriasis and Cardiovascular Symptoms: What to Know About Improving Health

News

Psoriasis is a chronic inflammatory disease with its most visible effects on the skin. However, psoriasis patients are at an elevated risk for many other conditions, particularly cardiovascular disease. In ... Read more

July 27, 2016

Gut Microbiome Could Be a Therapeutic Target to Manage Psoriasis

News

Interaction between the the immune system and the gut’s microbiome in the development of psoriasis and its accompanying lesions was the focus of the study, “Intestinal Microbiota Promotes Psoriasis-Like Skin Inflammation by Enhancing Th17 Response,” published ... Read more

July 25, 2016

Review Details Common Cellular, Immunological, Treatment Traits of Psoriasis, Inflammatory Bowel Disease

News

Psoriasis and inflammatory bowel disease (IBD), both chronic and inflammatory diseases, coexist in many patients and share genetic profiles. In a recent review, researchers explores and described the existing evidence ... Read more

July 22, 2016July 22, 2016

Erythrodermic Psoriasis Drug Review Calls for Guideline Update, Biologic Meds Included

News

Researchers at the University of California, Los Angeles recently provided a research review concerning treatment of erythrodermic psoriasis, a rare but severe version of common plaque psoriasis that effects at least 75% of the body. The ... Read more

July 21, 2016

Psoriasis Drug Siliq Supported by FDA Panel Despite Suicide Concerns

News

The U.S. FDA’s Dermatologic and Ophthalmic Drugs Advisory Committee voted unanimously for the approval of Valeant Pharmaceuticals’ Siliq (brodalumab). The full FDA is expected to make a decision on approval of the ... Read more

July 20, 2016July 20, 2016

Psoriasis: Symptom Severity, Quality of Life Sometimes Go Hand in Hand

News

Psoriasis is a dermatological disease that deeply impacts patients, not only physically but also emotionally when it comes to body image, self-esteem and overall quality of life. Researchers at the Medical University ... Read more

July 19, 2016

Review of Mental Health Problems in Psoriasis Patients Emphasizes Inflammatory Mechanisms

News

Reviewing published studies of the connection between psoriasis and mental health conditions, researchers in Portugal noted that the link is likely maintained by cascades of inflammatory factors triggered by chronic ... Read more

University of Michigan Researchers Identify 16 New Genetic Markers That Shed Light on Psoriasis

OWCP and mediq Collaborate to Introduce Cannabinoid-based Psoriasis Cream in Germany

FDA Approves BLA Filing for Sun Pharma’s Lead Candidate Therapy Tildrakizumab to Treat Plaque Psoriasis

Janssen’s Phase 3 Trials for Guselkumab to Focus on Plaque Psoriasis, Psoriatic Arthritis

Remicade Can Be Substituted for Less Expensive Biosimilar CT-P13, Clinical Trial Suggests

Cannabinoids Have Potential to Treat Skin Conditions Like Psoriasis, Review Shows

Phase 2b Trial of Psoriasis Therapy Prurisol Reaches 70% of Participant Target

Pfizer’s Xeljanz Reduced Nail Psoriasis in Phase 3 Trials of Plaque Disease

FDA Accepts Pfizer’s Supplemental New Drug Application for Xeljanz to Treat Active Psoriatic Arthritis Patients

Cimzia and Cosentyx Approved to Treat Active Psoriatic Arthritis in England and Wales

Valeant Prices Plaque Psoriasis Treatment, Siliq, at $3,500 a Month

XTRAC Light Therapy Effectively Treats Psoriasis Lesions Without the Serious Side Effects of Rival Therapies, Says Strata